Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Aaltomaa S et al. |
Eturauhassyöpä. Mitä uutta päivityksessä?
|
|
2 |
Aaltonen L-M et al. |
Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy.
|
|
3 |
Boye K et al. |
High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
|
|
4 |
De Souza Sabino SM et al. |
Implementation of a clinical quality control program in a mammography screening service of Brazil.
|
|
5 |
Grönroos TJ et al. |
Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
|
|
6 |
Haapaniemi A et al. |
Laryngeal cancer in Finland: A 5-year follow-up study of 366 patients.
|
|
7 |
Jambor I et al. |
Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
|
|
8 |
Jambor I et al. |
Evaluation of different mathematical models for diffusion-weighted imaging of normal prostate and prostate cancer using high b-values: A repeatability study.
|
|
9 |
Joensuu H et al. |
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).
|
|
10 |
Jyrkkiö S et al. |
Hodgkinin lymfooma.
|
|
11 |
Kero K et al. |
Smoking increases oral HPV peristence among men: 7-year follow-up study.
|
|
12 |
Kero KM et al. |
Stable marital relationship protects men from oral and genital HPV infections.
|
|
13 |
Kiviniemi A et al. |
Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
|
|
14 |
Knuuti J et al. |
Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease.
|
|
15 |
Koivu L et al. |
End-of-life pain medication among cancer patients in hospice settings.
|
|
16 |
Komar G et al. |
Prognostic value of tumour blood flow, (18F)EF% and (18F)FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.
|
|
17 |
Koskimaa H-M et al. |
Human papillomavirus 16 E2-, E6 and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohort.
|
|
18 |
Kurppa K et al. |
High frequency of BRAF V600E mutations in ameloblastoma.
|
|
19 |
Kurppa KJ et al. |
ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancerr.
|
|
20 |
Lindholm P. |
Pään ja kaulan alueen syöpien kemosädehoito.
|
|
21 |
Luoto P et al. |
11C-ORM-13070, a novel PET ligand for brain a2c-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
|
|
22 |
Luutonen S et al. |
Health-related quality of life during adjuvant radiotherapy in breast cancer.
|
|
23 |
Manceau G et al. |
Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
|
|
24 |
Minn H et al. |
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
|
|
25 |
Minn H et al. |
Hypoxia imaging for radiation therapy planning.
|
|
26 |
Mustonen M et al. |
Toremifene in the treatment of breast cancer.
|
|
27 |
Naillat F et al. |
ErbB4, a receptor tyrosine kinase, coordinates organization of the seminiferous tubules in the developing testis.
|
|
28 |
Paatero I et al. |
Hypoxia-inducible factor-1alpha induces ErbB4 signaling in the differentiating mammary gland.
|
|
29 |
Ragin C et al. |
HPV-associated lung cancers: an international pooled analysis.
|
|
30 |
Reid G et al. |
Harnessing microbiome and probiotic research in sub-Saharan Africa: recommendations from an African workshop.
|
|
31 |
Salminen E et al. |
Radiation protection of staff in PET centre activities - How to change from 'yes but' to 'will do' in staff radiation protection.
|
|
32 |
Seppänen M, Minn H. |
Positroniemissiotomografia syövän uusiutumisen ennustamisessa.
|
|
33 |
Siekkinen M et al. |
Randomized, controlled trial of the effect of e-feedback on knowledge about radiotherapy of breast cancer patients in Finland.
|
|
34 |
Siekkinen M et al. |
Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: a randomized controlled trial.
|
|
35 |
Silen J et al. |
Uptake of [18F]EF5 as a tracer for hypoxic and aggressive phenotype in experimental head and neck squamous cell carcinoma1.
|
|
36 |
Silvoniemi A et al. |
Evaluation of repeated [18F] EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas.
|
|
37 |
Taskinen M et al. |
Lapsuudessa tai nuoruudessa sairastettu syöpä parani - miten tukea terveyttä aikuisena?
|
|
38 |
Turunen A et al. |
The combined effects of irradiation and herpes simplex virus type 1 infection on an immortal gingival cell line.
|
|
39 |
Vihinen P. |
Katsaus ihomelanooman euroopalaiseen hoitosuositukseen.
|
|
40 |
Wright P et al. |
Isocentric integration of intensity-modulated radiotherapy with electron fields improves field junction dose uniformity in postmastectomy radiotherapy.
|
|
41 |
Ålgars A et al. |
Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.
|